Can Procter & Gamble Hit New Highs When It Reports Thursday Morning?
Procter & Gamble is set to report its fiscal second-quarter financial results after the closing bell on Wednesday, and analysts are looking for top and bottom line growth.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Procter & Gamble Co. (NYSE: PG | PG Price Prediction) is set to report its fiscal second-quarter financial results after the closing bell on Wednesday. The consensus estimates are calling for $1.37 in earnings per share (EPS) and $18.37 billion in revenue. In the same period of last year, the consumer products giant said it had $1.25 in EPS and $17.44 billion in revenue.
Back in the fiscal first quarter, net sales were up 7% from the prior year. Unfavorable foreign exchange was a 2% hurt to sales for the quarter. Excluding the impacts of foreign exchange, acquisitions and divestitures, organic sales increased 7%, driven by a 4% increase in organic shipment volume.
The company reported its segments as follows:
- Beauty revenues increased 10% year over year to $3.55 billion.
- Grooming revenues increased by 1% to $1.53 billion.
- Health Care revenues increased 9% to $2.22 billion.
- Fabric & Home Care revenues increased 8% to $5.83 billion.
- Baby, Feminine & Family Care revenues increased 5% to $4.57 billion.
In this report, management said that it would continue executing its strategies of superiority, productivity and constructive disruption and improving the company’s organization and culture to deliver balanced top and bottom line growth, along with strong cash generation in a challenging competitive and macroeconomic environment.
[nativounit]
Overall, Procter & Gamble stock has outperformed the broad markets with a gain of 38% in the past 52 weeks. However, over the past quarter, the shares are up just 7%.
Ahead of the report, a few analysts weighed in:
- Macquarie has an Outperform rating with a $138 price target.
- UBS Group has a Neutral rating and a $126 target price.
- Wells Fargo rates it as Outperform with a $136 target price.
- JPMorgan’s Overweight rating comes with a $139 price target.
- Morgan Stanley has an Overweight rating and a $134 price target.
Its shares were trading at $126.32 on Wednesday, in a 52-week range of $92.97 to $127.00. The consensus price target is $128.35.
[recirclink id=637284]
[wallst_email_signup]
Contact [email protected] for any questions or corrections.
Chris Lange is a financial and geopolitical writer with more than a decade of experience covering a myriad of topics. He has published thousands of articles for 24/7 Wall St., with past coverage focused heavily on stocks, IPOs, healthcare, defense, global affairs, and technology.
His work has been quoted, or referenced by a number of outlets including Business Insider, USA Today, Yahoo Finance, MSN, The Motley Fool, and many other publications. A graduate of Southwestern University, he studied business with a focus on investments and has previous experience in banking and startups.
When not reading or writing the news, he is following his passion for Lacrosse, playing chess, or building solar projects with his dad.
